The Gross Margin of Shield Therapeutics PLC (STX.L) is 30.78%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 30.78% |
| 2022-12-31 | 44.76% |
| 2021-12-31 | 35.48% |
| 2020-12-31 | 86.96% |
| 2019-12-31 | 32.55% |
| 2018-12-31 | 97.38% |
| 2017-12-31 | 75.67% |
| 2016-12-31 | 67.11% |